384 related articles for article (PubMed ID: 26166587)
21. Treatment of Lennox-Gastaut Syndrome (LGS).
Ferrie CD; Patel A
Eur J Paediatr Neurol; 2009 Nov; 13(6):493-504. PubMed ID: 19211283
[TBL] [Abstract][Full Text] [Related]
22. Rufinamide for the treatment of Lennox-Gastaut syndrome.
Besag FM
Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
[TBL] [Abstract][Full Text] [Related]
23. Lennox-Gastaut Syndrome: A State of the Art Review.
Mastrangelo M
Neuropediatrics; 2017 Jun; 48(3):143-151. PubMed ID: 28346953
[TBL] [Abstract][Full Text] [Related]
24. Asymmetric Slow-Spike-Wave Patterns with Maximal Discharges Contralateral to MRI Lesions Predict Better Surgical Prognosis in Symptomatic Lennox-Gastaut Syndrome or Lennox-Gastaut Phenotypes.
Yang MH; Liu J; Zhou YL; Yang H; Cai FC; Zempel J; Yang QW; Liu SY
Pediatr Neurosurg; 2020; 55(1):26-35. PubMed ID: 31851997
[TBL] [Abstract][Full Text] [Related]
25. Children With Trisomy 21 and Lennox-Gastaut Syndrome With Predominant Myoclonic Seizures.
Macdonald M; Crawford J; Datta AN
J Child Neurol; 2021 Oct; 36(11):1027-1033. PubMed ID: 34315269
[TBL] [Abstract][Full Text] [Related]
26. Early Diagnosis and Treatment of Lennox-Gastaut Syndrome.
Resnick T; Sheth RD
J Child Neurol; 2017 Oct; 32(11):947-955. PubMed ID: 28689466
[TBL] [Abstract][Full Text] [Related]
27. Use of the modified Atkins diet in Lennox Gastaut syndrome.
Sharma S; Jain P; Gulati S; Sankhyan N; Agarwala A
J Child Neurol; 2015 Apr; 30(5):576-9. PubMed ID: 24659735
[TBL] [Abstract][Full Text] [Related]
28. Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
Kim SH; Kang HC; Lee JS; Kim HD
Brain Dev; 2018 Nov; 40(10):897-903. PubMed ID: 30166208
[TBL] [Abstract][Full Text] [Related]
29. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
[TBL] [Abstract][Full Text] [Related]
30. Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.
Gresham J; Eiland LS; Chung AM
Neuropsychiatr Dis Treat; 2010 Oct; 6():639-45. PubMed ID: 20957124
[TBL] [Abstract][Full Text] [Related]
31. The role of surgery in the management of Lennox-Gastaut syndrome: A systematic review and meta-analysis of the clinical evidence.
Thirunavu V; Du R; Wu JY; Berg AT; Lam SK
Epilepsia; 2021 Apr; 62(4):888-907. PubMed ID: 33626200
[TBL] [Abstract][Full Text] [Related]
32. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Rev Neurother; 2024 Mar; 24(3):235-249. PubMed ID: 38315124
[TBL] [Abstract][Full Text] [Related]
33. Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.
Arzimanoglou A; Ferreira JA; Satlin A; Mendes S; Williams B; Critchley D; Schuck E; Hussein Z; Kumar D; Dhadda S; Bibbiani F
Eur J Paediatr Neurol; 2016 May; 20(3):393-402. PubMed ID: 26805435
[TBL] [Abstract][Full Text] [Related]
34. Lennox-Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures.
Vignoli A; Oggioni G; De Maria G; Peron A; Savini MN; Zambrelli E; Chiesa V; La Briola F; Turner K; Canevini MP
Epilepsy Behav; 2017 Dec; 77():73-78. PubMed ID: 29126048
[TBL] [Abstract][Full Text] [Related]
35. Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia.
You SJ; Lee JK; Ko TS
Brain Dev; 2007 Apr; 29(3):167-70. PubMed ID: 17005346
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
Sharawat IK; Panda PK; Panda P; Dawman L
Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
[TBL] [Abstract][Full Text] [Related]
37. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
[TBL] [Abstract][Full Text] [Related]
38. Budget impact analysis of antiepileptic drugs for Lennox-Gastaut syndrome.
Skornicki M; Clements KM; O'Sullivan AK
J Manag Care Spec Pharm; 2014 Apr; 20(4):400-6. PubMed ID: 24684645
[TBL] [Abstract][Full Text] [Related]
39. Ketogenic Diets in the Management of Lennox-Gastaut Syndrome-Review of Literature.
Skrobas U; Duda P; Bryliński Ł; Drożak P; Pelczar M; Rejdak K
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501006
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303.
Arzimanoglou A; Ferreira J; Satlin A; Olhaye O; Kumar D; Dhadda S; Bibbiani F
Eur J Paediatr Neurol; 2019 Jan; 23(1):126-135. PubMed ID: 30309816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
